Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial.
| Author | |
|---|---|
| Abstract |
:
To evaluate the efficacy, biological activity and safety of tregalizumab in patients with active rheumatoid arthritis (RA) and an inadequate response to methotrexate (MTX). |
| Year of Publication |
:
2018
|
| Journal |
:
Annals of the rheumatic diseases
|
| Date Published |
:
2018
|
| ISSN Number |
:
0003-4967
|
| URL |
:
http://ard.bmj.com/cgi/pmidlookup?view=long&pmid=29343509
|
| DOI |
:
10.1136/annrheumdis-2017-212478
|
| Short Title |
:
Ann Rheum Dis
|
| Download citation |
